Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CCCC
FENC
Add up to 3 more stocks
CCCC
C4 Therapeutics, Inc.
-3.68%
$2.88-0.11Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$318.43M
52W Range
$1.69 - $5.17
FENC
Fennec Pharmaceuticals Inc.
-2.54%
$10.35-0.27Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$359.53M
52W Range
$5.65 - $13.25
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | 36.53 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 1.29 | 8.47 |
| P/S Ratio | 9.09 | 6.07 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 77.8% | 93.7% |
| Operating Margin | -290.7% | -14.2% |
| Net Margin | -289.4% | -5.5% |
| ROE | -41.0% | -7.7% |
| ROA | -28.2% | -4.3% |
| ROIC | -35.9% | -1.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 5.45 | 5.85 |
| Quick Ratio | 5.45 | 5.66 |
| Debt/Equity | 0.23 | 0.00 |
| Interest Coverage | N/A | -3.05 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.